Cargando…

Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy

BACKGROUND: Recent evidence suggests that patients with herpes simplex virus (HSV) encephalitis may relapse because of autoimmunity against the N-methyl-D-aspartate receptor (NMDAR). We present a case series of post-HSV relapsing encephalopathy associated with antibodies to central nervous system (C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alexopoulos, Harry, Akrivou, Sofia, Mastroyanni, Sotiria, Antonopoulou, Maria, Dinopoulos, Argirios, Giorgi, Melpo, Konstantinou, Kostas, Kouremenos, Evangelos, Lariou, Maria, Naoumis, Dimitrios, Pavlidou, Efterpi, Pavlou, Evaggelos, Voudris, Konstantinos, Vlachoyiannopoulos, Panayotis, Dalakas, Marinos C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949951/ https://www.ncbi.nlm.nih.gov/pubmed/29774053 http://dx.doi.org/10.1177/1756286418768778

Ejemplares similares

Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis
por: Kosmidis, Michalis L., et al.
Publicado: (2019)

Autoimmune encephalitis with GABA(B) antibodies, thymoma, and GABA(B) receptor thymic expression
por: Alexopoulos, Harry, et al.
Publicado: (2014)

Postherpes zoster programmed death-1 inhibitor−associated zosteriform granulomatous reactions
por: Chadha, Simran A., et al.
Publicado: (2020)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

Bilateral Eyelid Ptosis, Attributed to Vincristine, Treated Successfully with Pyridoxine and Thiamine in a Child with Acute Lymphoblastic Leukemia
por: Hatzipantelis, Emmanuel, et al.
Publicado: (2015)

Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece
por: Vlachoyiannopoulos, Panayiotis, et al.
Publicado: (2020)

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
por: Alexopoulos, Harry, et al.
Publicado: (2020)

Antiphospholipid and Antinuclear Antibodies in Children with Idiopathic Epilepsy: A 2-Year Prospective Study
por: Attilakos, Achilleas, et al.
Publicado: (2020)

Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
por: Rakocevic, Goran, et al.
Publicado: (2019)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
por: Dalakas, Marinos C., et al.
Publicado: (2021)

GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions
por: Tsiortou, Popianna, et al.
Publicado: (2021)

Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients
por: Kampylafka, Eleni I., et al.
Publicado: (2013)

Complement in neurological disorders and emerging complement-targeted therapeutics
por: Dalakas, Marinos C., et al.
Publicado: (2020)

Lumbar puncture complicated by spinal epidural hematoma in a child with leukemia
por: Hatzipantelis, Emmanuel, et al.
Publicado: (2015)

Erythromelalgia in an Adolescent Female
por: Mamatsi, Eleftheria, et al.
Publicado: (2022)

Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
por: Dalakas, Marinos C.
Publicado: (2018)

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system
por: Dalakas, Marinos C.
Publicado: (2018)

Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost
por: Dalakas, Marinos C.
Publicado: (2017)

Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease: More to come with myositis in the offing
por: Dalakas, Marinos C.
Publicado: (2020)

Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications
por: Dalakas, Marinos C.
Publicado: (2020)

Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
por: Dalakas, Marinos C.
Publicado: (2021)

IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2021)

Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2022)

Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies
por: Dalakas, Marinos C.
Publicado: (2022)

Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology
por: Dalakas, Marinos C.
Publicado: (2023)

Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: What we learnt from consensus criteria in CIDP, Myasthenia Gravis and Inflammatory Myopathies
por: Dalakas, Marinos C.
Publicado: (2023)

Comment on Childhood Febrile Seizures: Overview and Implications by Tonia Jones and Steven J. Jacobsen
por: Pavlidou, Efterpi, et al.
Publicado: (2007)

Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine
por: Kouremenos, Evangelos, et al.
Publicado: (2019)

The Greek Version of Mini-Manual Ability Classification System (Mini-MACS): Translation and Reliability Study
por: Skoutelis, Vasileios C, et al.
Publicado: (2022)

Autoimmune Neurogenic Dysphagia
por: Stathopoulos, Panos, et al.
Publicado: (2021)

Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
por: Stathopoulos, Panos, et al.
Publicado: (2022)

Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody–Positive Stiff-Person Syndrome
por: Yi, Jessica, et al.
Publicado: (2022)

Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies
por: Dalakas, Marinos C., et al.
Publicado: (2022)

Effect of Levetiracetam Monotherapy on Liver Enzymes and Creatine Kinase Concentrations in Children with Epilepsy: A Prospective Study
por: Attilakos, Achilleas, et al.
Publicado: (2018)

Short-Term and Long-Term Effects of Levetiracetam Monotherapy on Homocysteine Metabolism in Children with Epilepsy: A Prospective Study
por: Attilakos, Achilleas, et al.
Publicado: (2019)

The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Redox Status of Pregnant Ewes after Vaccination against Clostridial Diseases
por: Stampinas, Evaggelos-Georgios, et al.
Publicado: (2022)

Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy
por: Rakocevic, Goran, et al.
Publicado: (2018)

Aggressive Herpes Zoster in Young Patients With Multiple Sclerosis Under Dimethyl Fumarate: Significance of CD8(+) and Natural Killer Cells
por: Anagnostouli, Maria C., et al.
Publicado: (2021)

Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?
por: Kohle, Felix, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c83c7tph863mjvpik52cmvf4ag